Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06141850 · ClinicalTrials.gov registry record · NA
Promoting Engagement and COVID-19 Testing for Health
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 290
- Enrollment target
NCT06141850: Completed NA study, sponsored by Emory University.
NCT06141850 is a NA study that has completed, run by Emory University. The registered enrollment target is 290 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06141850, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
Study Summary
PEACH2 is a community-based study, targeting individuals affected by diabetes. Study participants will be randomized into the PEACH2 Intervention Arm or the Control Arm. The intervention lasts for 16 weeks and participants will be followed for 12 months in total.
Primary Outcome
The number of individuals who reported (1) having COVID or COVID-like symptoms and (2) taking a COVID-19 test in the past month as reported using survey data (baseline only) or the text-based COVID-19 reporting tool created for this study (weeks 4, 8, and 12).
Interventions
- BEHAVIORAL COVID-19 Test Reporting
- BEHAVIORAL Personalized Nudges via Text Messaging
- BEHAVIORAL Non-personalized Nudges via Text Messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2023-12-06 |
| Est. Completion | 2025-03-25 |
| Phase | NA |
What the finished NCT06141850 record still lists
NCT06141850 is an interventional study that assigns participants to a tested intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 3 interventions - of which COVID-19 Test Reporting is the first listed.
NCT06141850 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06141850 about?
NCT06141850 is a clinical study titled "Promoting Engagement and COVID-19 Testing for Health". PEACH2 is a community-based study, targeting individuals affected by diabetes. Study participants will be randomized into the PEACH2 Intervention Arm or the Control Arm. The intervention lasts for 16 weeks and participants will be followed for 12 months in total.
What is the current status of trial NCT06141850?
This trial is currently completed. It is a NA study. The enrollment target is 290 participants. The study started on 2023-12-06. Estimated completion is 2025-03-25.
What interventions are being tested in trial NCT06141850?
The interventions under investigation include: COVID-19 Test Reporting (BEHAVIORAL), Personalized Nudges via Text Messaging (BEHAVIORAL), Non-personalized Nudges via Text Messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT06141850?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06141850's enrollment target sits among peer trials
290 375th of 2000 higher than 1,625 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI